Vemurafenib (ZELBORAF ® tablet 240 mg): pharmacological properties and clinical development overview.

Subjects

Subjects :

Antineoplastic Agents administration & dosage
Antineoplastic Agents chemistry
Antineoplastic Agents therapeutic use
Clinical Trials as Topic
Humans
Indoles administration & dosage
Indoles chemistry
Indoles therapeutic use
Neoplasms genetics
Proto-Oncogene Proteins B-raf genetics
Sulfonamides administration & dosage
Sulfonamides chemistry
Sulfonamides therapeutic use
Tablets
Vemurafenib
Antineoplastic Agents pharmacology
Indoles pharmacology
Neoplasms drug therapy
Sulfonamides pharmacology

Details

Language :

Japanese

ISSN :

0015-5691

Volume :

148

Issue :

4

Database :

MEDLINE

Journal :

Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Publication Type :

Academic Journal

Accession number :

27725568

Full Text :

https://doi.org/10.1254/fpj.148.197